Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
Apply
CGX1321, Pembrolizumab, Encorafenib, Cetuximab
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step